ACTIVE

APOTHEEK MOLENVELD

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result125,4 k €-21,4 %over 1 year

Gross margin246,4 k €-7,3 %over 1 year

Equity142,7 k €0,0 %over 1 year

Workforce0,8 ETP+33,3 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK MOLENVELD is a Public limited company incorporated in 1983. Its registered office is in Grimbergen. It employs on average 0,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0424.329.567
Incorporation: 08/07/1983
Legal form: Public limited company
Registered office: Groot-Molenveldlaan 2
1850 Grimbergen · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 0,8 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	246,4 k €	-7.3%	265,7 k €	+39.2%	190,8 k €	+84.7%	103,3 k €	+6.7%	96,8 k €
EBITDA	195,4 k €	-15.9%	232,2 k €	+69.7%	136,8 k €	+169%	50,9 k €	+4.0%	49 k €
Operating result	178,4 k €	-20.0%	223 k €	+69.9%	131,2 k €	+183%	46,4 k €	+29.5%	35,9 k €
Net result	125,4 k €	-21.4%	159,6 k €	+72.4%	92,6 k €	+226%	28,4 k €	+10.9%	25,6 k €
Balance sheet
Equity	142,7 k €	0.0%	142,7 k €	0.0%	142,7 k €	0.0%	142,7 k €	-13.2%	164,3 k €
Total assets	456,9 k €	-27.2%	627,6 k €	+3.2%	607,9 k €	+28.6%	472,7 k €	+15.0%	411,1 k €
Cash	34,3 k €	+18.3%	29 k €	-60.8%	74,1 k €	-46.6%	138,7 k €	-1.3%	140,6 k €
Debts	314,2 k €	-35.1%	484,4 k €	+4.1%	465,2 k €	+41.0%	330 k €	+35.2%	244,1 k €
Other
Workforce	0,8 ETP	+33.3%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 9 ended

Active mandates

E.V.N. PHARMA

Director · since 30 juin 2022 · until 30 juin 2028 · 0871.125.128

Represented by Peggy Van den Wyngaert

Active

EVN CONSULTING

Director · since 30 juin 2022 · until 30 juin 2028 · 0806.117.213

Represented by Eric VAN NUETEN

Active

Ended mandates

ERSAPO

Director · since 20 décembre 2017 · until 20 décembre 2023 · 0861.561.225

Represented by Erik Vanbeselaere

Ended

Saskia De Doncker

Director · since 20 décembre 2017 · until 20 décembre 2023

Ended

Eric Vanbeselaere

Director · since 20 novembre 2011

Ended

ERSAPO

Director · since 20 novembre 2011 · 0861.561.225

Represented by Erik Vanbeselaere

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/08/2026	28/08/2025	02/08/2024	30/08/2023	13/06/2022	28/06/2021
General meeting	25/06/2026	25/06/2025	25/06/2024	26/06/2023	16/05/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	25/06/2026	04/08/2026	Dutch	PDF
Abridged model	31/12/2024	25/06/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	25/06/2024	02/08/2024	Dutch	PDF
Abridged model	31/12/2022	26/06/2023	30/08/2023	Dutch	PDF
Abridged model	31/12/2021	16/05/2022	13/06/2022	Dutch	PDF
Abridged model	31/12/2020	25/06/2021	28/06/2021	Dutch	PDF
Abridged model	31/12/2019	25/06/2020	26/06/2020	Dutch	PDF
Abridged model	31/12/2018	25/06/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	25/06/2018	24/07/2018	Dutch	PDF
Abridged model	31/12/2016	26/06/2017	14/07/2017	Dutch	PDF
Abridged model	31/12/2015	25/06/2016	15/07/2016	Dutch	PDF
Abridged model	31/12/2014	25/06/2015	29/06/2015	Dutch	PDF
Abridged model	31/12/2013	25/06/2014	27/06/2014	Dutch	PDF
Abridged model	31/12/2012	25/06/2013	28/06/2013	Dutch	PDF
Abridged model	31/12/2011	15/06/2012	05/07/2012	Dutch	PDF
Abridged model	31/12/2010	04/06/2011	24/08/2011	Dutch	PDF
Abridged model	31/12/2009	04/06/2010	12/08/2010	Dutch	PDF
Abridged model	31/12/2008	02/06/2009	04/06/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	11/07/2008	Dutch	PDF
Abridged model	31/12/2006	01/06/2007	11/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 9 ended

Active mandates

E.V.N. PHARMA

Director · since 30 juin 2022 · until 30 juin 2028 · 0871.125.128

Represented by Peggy Van den Wyngaert

Active

EVN CONSULTING

Director · since 30 juin 2022 · until 30 juin 2028 · 0806.117.213

Represented by Eric VAN NUETEN

Active

Ended mandates

ERSAPO

Director · since 20 décembre 2017 · until 20 décembre 2023 · 0861.561.225

Represented by Erik Vanbeselaere

Ended

Saskia De Doncker

Director · since 20 décembre 2017 · until 20 décembre 2023

Ended

Eric Vanbeselaere

Director · since 20 novembre 2011

Ended

ERSAPO

Director · since 20 novembre 2011 · 0861.561.225

Represented by Erik Vanbeselaere

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates31/08/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/09/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/01/2012
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates23/01/2004
DEMISSIONS, NOMINATIONS
PDF
Mandates22/01/2004
ONTSLAGEN - BENOEMINGEN - BENAMING
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025125,4 k €↓
2024
Annual accounts 2024159,6 k €↑
2023
Annual accounts 202392,6 k €↑
2022
Annual accounts 202228,4 k €↑
2021
Annual accounts 202125,6 k €↓
2020
Annual accounts 2020129,6 k €↑
2019
Annual accounts 201941,9 k €↑
2018
Annual accounts 20183,9 k €↑
2017
Annual accounts 2017211,8 €↓
2016
Annual accounts 201628,6 k €↑
2015
Annual accounts 201527,8 k €↑
2014
Annual accounts 201427,1 k €↓
2013
Annual accounts 201371,3 k €↑
2012
Annual accounts 201260,1 k €↑
2011
Annual accounts 201152,7 k €↑
2010
Annual accounts 201022,5 k €↓
2009
Annual accounts 200953 k €↑
2008
Annual accounts 200840,4 k €↑
2007
Annual accounts 200739,8 k €
08/07/1983
IncorporationPublic limited company

APOTHEEK MOLENVELD

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline